---
title: MBT-2 Syngeneic Model - TD2 Precision Oncology
description: Explore the MBT-2 cancer cell line, a valuable tool in bladder cancer research. Study tumor biology, metastasis, and therapeutic interventions for better diagnosis and treatment.
image: https://td2inc.com/hubfs/Assets/GraphsFigures/mbt-2.png
---

×

 

[![td2-logo](https://td2inc.com/hubfs/td2-logo.png "td2-logo")](https://td2inc.com/?hsLang=en)

![Search Site](https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png)

[![td2-logo](https://td2inc.com/hubfs/td2-logo.png "td2-logo")](https://td2inc.com/?hsLang=en)

![Search Site](https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png)

# MBT-2 Syngeneic Model

**Synonyms:** MBT2 bladder cancer cell line, MBT-2 bladder tumor cell line

MBT-2 is a well-known cancer cell line derived from murine bladder tumors. It serves as a valuable tool in bladder cancer research, offering insights into tumor biology, metastasis, and therapeutic interventions. The cells exhibit an epithelial morphology and can form tumors when implanted into animal models. Researchers utilize MBT-2 to study various aspects of bladder cancer, including genetic alterations, signaling pathways, immune responses, and drug sensitivity. It has been extensively employed in preclinical models to evaluate the efficacy of different treatment approaches such as chemotherapy, immunotherapy, and targeted therapies. The MBT-2 cell line plays a crucial role in advancing our understanding of bladder cancer and developing new strategies for its diagnosis and treatment.

## Model Details

**Cancer Type:** Bladder Cancer  
**Model Name:** MBT-2  
**Mouse Strain:** C3H  
**Treatment Data Available:** aCTLA-4

## MBT-2 Growth Curves

![MBT-2 Syngeneic Model](https://td2inc.com/hubfs/Assets/GraphsFigures/mbt-2.png)

Growth of subcutaneous MBT-2 in C3H mice (n=5)

### Request Additional Syngeneic Model Data

## CONTACT US

## Get Started.

Have questions about how TD2 can assist with your regulatory needs? Reach out to our expert staff today to get started.

[Get Started Now](https://td2inc.com/contact-us/?hsLang=en)

[![td2-logo-footer](https://td2inc.com/hs-fs/hubfs/td2-logo.png?width=160&name=td2-logo.png)](https://td2inc.com/?hsLang=en)

Office  
13208 E. Shea Blvd,   
Suite 100   
Scottsdale, AZ 85259

Phone  
(602) 358-8300

Connect with us

- <https://www.linkedin.com/company/translational-drug-development/>
- <https://twitter.com/TD2_Oncology>

![td2-logo-footer](https://td2inc.com/hs-fs/hubfs/Assets/Logo/acclac-logo.png?width=139&name=acclac-logo.png)

© 2026 Translational Drug Development. All Rights Reserved. [Terms and Conditions](https://td2inc.com/terms-and-conditions?hsLang=en) | [Privacy Policy](https://td2inc.com/privacy-policy?hsLang=en)